The effect of infliximab on bone metabolism markers in patients with rheumatoid arthritis

Rheumatology

Volumn 45, Issue 6, 2006, Pages 761-764

  Torikai, Eiji ^a   Kageyama, Y ^a   Takahashi, M ^a   Suzuki, M ^a   Ichikawa, T ^a   Nagafusa, T ^a   Nagano, A ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone metabolism marker; Infliximab; NTX; Rheumatoid arthritis

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; C REACTIVE PROTEIN; DEOXYPYRIDINOLINE; INFLIXIMAB; METHOTREXATE; PREDNISOLONE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTHRALGIA; ARTICLE; BONE METABOLISM; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE MARKER; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; JOINT SWELLING; MALE; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

ALKALINE PHOSPHATASE; AMINO ACIDS; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BONE REMODELING; BONE RESORPTION; COLLAGEN TYPE I; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; PEPTIDES; SEVERITY OF ILLNESS INDEX;

EID: 33745595892     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei280     Document Type: Article

References (30)

1. Sambrook PN. The skeleton in rheumatoid arthritis; common mechanisms for bone erosion and osteoporosis? J Rheumatol 2002; 27:2541-2.
2. Joffe I, Epstein S. Osteoporosis associated with rheumatoid arthritis: pathogenesis and management. Semin Arthritis Rheum 1991;20: 256-72.
3. Deodhar AA, Woolf AD. Bone mass measurement and bone metabolism of rheumatoid arthritis: A review. Br J Rheumatol 1996;35;309-22.
4. Martin JC, Munro R, Cambell MK, Reid DM. Effects of disease and corticosteroids in appendicular bone mass in postmenopausal women with rheumatoid arthritis comparison with axial measurements. Br J Rheumatol 1997;36:43-9.
5. Celiker R, Gokce-Kutsal Y, Cindas A et al. Osteoporosis in rheumatoid arthritis effect of disease activity. Clin Rheumatol 1995;14:429-33.
6. Laan RF, van Riel PL, van de Pute LB. Bone mass in patients with rheumatoid arthritis. Ann Rheum Dis 1992;51:826-32.
7. Kallia AA, Meyels OL, Laubscher R. Prevalence of metacarpal osteopenia in young rheumatoid arthritis patients. Clin Rheumatol 1995;14:617-25.
8. Delin J, Lilley J, Gough A et al. Clinical associations of dual-energy X-ray absorptiometry measurement of hand bone mass in rheumatoid arthritis. Br J Rheumatol 1996;35:1256-62.
9. Magaro M, Tricerri A, Piane D, Zoli A, Serra F, Altmonte L, Mirone L. Generalized osteoporosis in non-steroid-treated rheumatoid arthritis. Rheumatol Int 1991;11:73-6.
10. Arend WP, Dayer JM. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum 1995;38:151-60.
11. Maini RN, Taylor PC. Anti-cytokine therapy for rheumatoid arthritis. Annu Rev Med 2000;51:207-29.
12. Taylor PC. Anti-TNF alpha therapy for rheumatoid arthritis: An update. Intern Med 2003;432:15-20.
13. Cairns AP, Taggart AJ. Anti-tumor necrosis factor therapy for severe inflammatory arthritis: Two years of experience in Northern Ireland. Ulster Med J 2002;71:101-5.
14. Garnero P, Delmas PD. New developments in biochemical markers for osteoporosis. Calcif Tissue Int 1996;59(Suppl. 1):82-9.
15. Gough AK, Peel NF, Eastell R, Holder RL, Lilley J, Emery P. Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis. Ann Rheum Dis 1994;53:14-7.
16. Kollerup G, Hansen M, Horslev PK. Urinary hydroxyproline crosslinks of collagen in rheumatoid arthritis. Br J Rheumatol 1994;33:816-20.
17. Pereira RM, Corrente J, Chahade W, Cossermelli W. Levels of deoxypyridinoline cross-links in healthy children and children with juvenile rheumatoid arthritis [abstract]. Arthritis Rheum 1996;7:902-6.
18. Vis GJ, Wolbink MC, Lodder PJ et al. Early changes in bone metabolism in rheumatoid arthritis patients treated with infliximab. Arthritis Rheum 2003;10:2996-7.
19. Thomson BM, Mundy GR, Chambers TJ. Tumour necrosis factor alpha and beta induce osteoblastic cells to stimulate osteoclast bone resorption. J Immunol 1987;138:775-80.
20. Fujikawa Y, Kudo O, Taira H, Itonoga J, Torisu T. Tumour necrosis factor alpha acts directly on osteoclast formation by synovial macrophages and monocytes in rheumatoid arthritis. Ann Rheum Dis 2001:6-49.
21. Azuma Y, Kaji K, Katori R, Takeshita S, Kudo A. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem 2000;275:4858-64.
22. Zhang YH, Heulsmann A, Tondravi MM, Mukherjee A, Abu-Amer Y. Tumor necrosis factor-alpha (TNF) stimulates RANK signaling pathways. J Biol Chem 2001;276:563-8.
23. Kobayashi K, Takahashi K, Jimi E. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/ RANKL-RANK interaction. J Exp Med 2000;191:275-86.
24. Jijmi E, Akiyama S, Tsurukai T. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J Immunol 1999;163:434-42.
25. Fuller K, Wong B, Fox S. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med 1998;188:997-1001.
26. Greenspan S, Rosen H, Parker R. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: A randomized clinical trial. J Bone Miner Res 1998;13: 1431-8.
27. Ravn P, Clemmesen B, Christiansen C. Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Bone 1999;24:237-44.
28. St Clair EW, Moak SA, Wilkinson WE, Sanders L, Lang T, Greenwald RA. A cross sectional analysis of 5 different markers of collagen degradation in rheumatoid arthritis. J Rheumatol 1998;25:1472-9.
29. Hall GM, Spector TD, Delmas PD. Markers of bone metabolism in postmenopausal women with rheumatoid arthritis: Effects of corticosteroids and hormone replacement therapy. Arthritis Rheum 1995;38:902-6.
30. Yasser M, Iman H, Mohamed EL. Effect of low dose methotrexate on markers of bone metabolism in patients with rheumatoid arthritis. J Rheumatol 1998;25:2083-7.